ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
0.5884
-0.0186 (-3.06%)
Apr 25, 2025, 4:00 PM EDT - Market closed

ProMIS Neurosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
----0
Upgrade
Revenue Growth (YoY)
----32.47%
Upgrade
Cost of Revenue
10.647.8816.094.632.5
Upgrade
Gross Profit
-10.64-7.88-16.09-4.63-2.5
Upgrade
Selling, General & Admin
2.695.585.993.661.95
Upgrade
Operating Expenses
2.695.585.993.661.95
Upgrade
Operating Income
-13.33-13.46-22.08-8.29-4.44
Upgrade
Interest Expense
-0.08-0.2-0.28-0.42-
Upgrade
Interest & Investment Income
----0
Upgrade
Other Non Operating Income (Expenses)
19.681.254.29-1.08-
Upgrade
EBT Excluding Unusual Items
6.28-12.41-18.07-9.79-4.44
Upgrade
Other Unusual Items
-3.5-0.80.01--
Upgrade
Pretax Income
2.78-13.21-18.06-9.79-4.44
Upgrade
Net Income
2.78-13.21-18.06-9.79-4.44
Upgrade
Net Income to Common
2.78-13.21-18.06-9.79-4.44
Upgrade
Shares Outstanding (Basic)
2612865
Upgrade
Shares Outstanding (Diluted)
2612865
Upgrade
Shares Change (YoY)
115.26%63.85%29.68%21.55%9.93%
Upgrade
EPS (Basic)
0.11-1.07-2.41-1.69-0.93
Upgrade
EPS (Diluted)
0.11-1.07-2.41-1.69-0.93
Upgrade
Free Cash Flow
-27.18-10.84-17.04-9.31-3.5
Upgrade
Free Cash Flow Per Share
-1.03-0.88-2.27-1.61-0.74
Upgrade
Operating Margin
-----361893.65%
Upgrade
Profit Margin
-----361879.48%
Upgrade
Free Cash Flow Margin
-----285250.81%
Upgrade
EBITDA
-13.31-13.44-22.07-8.25-4.43
Upgrade
D&A For EBITDA
0.020.020.010.050.01
Upgrade
EBIT
-13.33-13.46-22.08-8.29-4.44
Upgrade
Revenue as Reported
----0
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q